Signori Roberta, Barbosa Antony de Paula, Cezar-Dos-Santos Fernando, Carbone Ana Claudia, Ventura Silvio, Nobre Bryanne Brissian de Souza, Neves Maria Luiza Boechat Borges, Câmara-Souza Mariana Barbosa, Poluha Rodrigo Lorenzi, De la Torre Canales Giancarlo
Egas Moniz Center for Interdisciplinary Research (CiiEM), Egas Moniz School of Health & Science, 2829-511 Caparica, Almada, Portugal.
Department of Research & Development, Health & Aesthetics, Antony Barbosa Institute, Belo Horizonte 31270-901, Minas Gerais, Brazil.
Polymers (Basel). 2024 Sep 11;16(18):2564. doi: 10.3390/polym16182564.
The primary objective of this systematic review study was to investigate the effectiveness, durability, and adverse events of PLLA treatment for aesthetic indications. The search strategy was performed in MEDLINE (Ovid). The electronic literature search of five databases was performed, from the inception of the databases until the 12th of February 2024. This was to identify randomized clinical trials that assessed PLLA treatment in adult individuals exhibiting facial aging and/or facial lipoatrophy. Risk of bias was assessed using the Cochrane Risk-of-Bias Tool for Randomized Trials (RoB 2). Eleven RCTs out of 1467 identified citations were included. Four studies showed increased dermal thickness, significant improvement in facial lipoatrophy severity and aesthetic clinical scores, after PLLA treatment with its effects sustained for at least 25 months. Two studies demonstrated the superiority of PLLA over injectable human collagen. Also, three studies showed positive results favoring PLLA when compared with PH gel in lipoatrophy severity, transepidermal water loss, skin quality, elasticity, and patient satisfaction. All adverse events were mild-to-moderate in intensity, and the main ones worth noting were bruising, hematoma, tenderness, nodules, and edema. Five out of eleven studies were considered having high risk of bias. The evidence on the effectiveness and safety of PLLA for facial rejuvenation is of low quality; thus, the reported high effectiveness, safety, and long-lasting effects for this purpose should be further investigated.
本系统评价研究的主要目的是调查聚左旋乳酸(PLLA)治疗美容适应症的有效性、持久性和不良事件。检索策略在MEDLINE(Ovid)中进行。对五个数据库进行了电子文献检索,检索时间从数据库建立至2024年2月12日。目的是识别评估PLLA治疗面部衰老和/或面部脂肪萎缩成年个体的随机临床试验。使用Cochrane随机试验偏倚风险工具(RoB 2)评估偏倚风险。在1467条被识别的引文中,纳入了11项随机对照试验(RCT)。四项研究表明,PLLA治疗后真皮厚度增加,面部脂肪萎缩严重程度和美容临床评分显著改善,其效果持续至少25个月。两项研究证明PLLA优于可注射的人胶原蛋白。此外,三项研究表明,与PH凝胶相比,PLLA在脂肪萎缩严重程度、经表皮水分流失、皮肤质量、弹性和患者满意度方面有积极结果。所有不良事件的强度均为轻度至中度,主要值得注意的是瘀伤、血肿、压痛、结节和水肿。11项研究中有5项被认为存在高偏倚风险。PLLA用于面部年轻化的有效性和安全性证据质量较低;因此,为此目的所报道的高有效性、安全性和长效效果应进一步研究。